Gaucher Disease Information
- Publish Date: 2009/04/02
- Author: Sally Rider
Outline: Gaucher disease is an inherited metabolic disorder in which fatty substance called glucocerebroside accumulate in the spleen liver lungs bone marrow and the brain.
Main DigestGaucher disease (GD) is an inherited metabolic disorder in which harmful quantities of a fatty substance called glucocerebroside accumulate in the spleen, liver, lungs, bone marrow, and sometimes in the brain.
Gaucher disease (GD) is an inherited metabolic disorder in which harmful quantities of a fatty substance called glucocerebroside accumulate in the spleen, liver, lungs, bone marrow, and sometimes in the brain.
Alternative Names: Gaucher disease-Type 2; GD2; Gaucher disease, infantile cerebral; Gaucher disease, acute neuronopathic type; Gaucher's disease type 2; Gaucher's disease type 2; Gaucher syndrome type 2
In GD Type 2, liver and spleen enlargement are apparent by 3 months of age. Children have extensive and progressive brain damage and usually die by 2 years of age.
All GD individuals exhibit a deficiency of an enzyme called glucocerebrosidase that is involved in the breakdown and recycling of glucocerebroside. The buildup of this fatty material within cells prevents the cells and organs from functioning properly. GD is one of several lipid storage diseases.
The diagnosis of GD relies on demonstration of deficient glucosylceramidase enzyme activity in peripheral blood leukocytes or other nucleated cells. Identification of two disease-causing alleles in GBA, the only gene known to be associated with GD, provides additional confirmation of the diagnosis but not in lieu of biochemical testing. Molecular genetic testing using sequence analysis identifies mutations in the majority of affected individuals.
There is no effective treatment for the severe brain damage that may occur in children with GD Type 2.
The prognosis for children with GD Type 2 with onset before age two years is limited psychomotor development and a rapidly progressive course with death by age two to four years.
- 1 - Osgood-Schlatters Disease: Causes, Diagnosis and Treatments | Disabled World | 2009/03/20
- 2 - Screening Lowers Severe Jaundice Risk in Babies | University of California San Francisco | 2009/09/28
- 3 - Jaundice in the Newborn Baby | Cecilia Koh | 2017/10/03
- 4 - Coaxing Kids Through Vaccinations - Pain Expectation is Pain Reality for Children | University of California - Riverside | 2018/06/04
- 5 - Fetal Alcohol Spectrum Disorder in Children | JoAnn Collins | 2009/03/23
- 6 - Types of Genetic Mutations Associated with Nephrotic Syndrome Identified | Fundação de Amparo à Pesquisa do Estado de São Paulo | 2018/03/24
- 7 - SIDS: Sudden Infant Death Syndrome Information | Disabled World | 2009/02/19
- 8 - Siblings of Cot Death Victims Have Four Times SIDS Risk | European Society of Cardiology | 2018/03/19
Help Spread Disability AwarenessConnect with Us on Social Media